A Distributed Delay Approach for Modeling Delayed Outcomes in Pharmacokinetics and Pharmacodynamics Studies Publication A Distributed Delay Approach for Modeling Delayed Outcomes in Pharmacokinetics and Pharmacodynamics Studies Certara2017 年 10 月 30 日
Influence of Molecular Size on the Clearance of Antibody Fragments Publication Influence of Molecular Size on the Clearance of Antibody Fragments Certara2017 年 10 月 1 日
Drug Asset Evaluation: Increasing “Probability of Success” of a Deal White Paper 药物资产评估:提高交易的 "成功概率” Certara’s due diligence/asset evaluation teams are comprised of drug development and commercialization experts who advise…Certara2017 年 8 月 24 日
Parent‐metabolite Pharmacokinetic Modeling and Pharmacodynamics of Veliparib (ABT‐888), a PARP Inhibitor, in Patients with BRCA 1/2–mutated Cancer or PARP‐sensitive Tumor Types Publication Parent‐metabolite Pharmacokinetic Modeling and Pharmacodynamics of Veliparib (ABT‐888), a PARP Inhibitor, in Patients with BRCA 1/2–mutated Cancer or PARP‐sensitive Tumor Types Certara2017 年 8 月 1 日
Response Analysis of Alvocidib (Flavopiridol) Treatment by Bolus or Hybrid Administration in Newly Diagnosed or Relapsed/Refractory Acute Leukemia Patients Publication Response Analysis of Alvocidib (Flavopiridol) Treatment by Bolus or Hybrid Administration in Newly Diagnosed or Relapsed/Refractory Acute Leukemia Patients Certara2017 年 7 月 15 日
Interdisciplinary Pharmacometrics Linking Oseltamivir Pharmacology, Influenza Epidemiology and Health Economics to Inform Antiviral Use in Pandemics Publication Interdisciplinary Pharmacometrics Linking Oseltamivir Pharmacology, Influenza Epidemiology and Health Economics to Inform Antiviral Use in Pandemics Certara2017 年 7 月 1 日
Time Dependent Pharmacokinetics of Pembrolizumab in Patients with Solid Tumor and Its Correlation with Best Overall Response Publication Time Dependent Pharmacokinetics of Pembrolizumab in Patients with Solid Tumor and Its Correlation with Best Overall Response Certara2017 年 6 月 1 日
Obeticholic Acid—From PK Model to Drug Label On-Demand Webinar Obeticholic Acid—From PK Model to Drug Label Watch this webinar with Jeffrey Edwards to learn how he used physiologic pharmacokinetic modeling to…Certara2017 年 6 月 1 日
Using pharmacokinetics to assure chemical food safety Blog Using pharmacokinetics to assure chemical food safety As a veterinarian, I’m responsible for the health and welfare of my animal patients. Sometimes,…Certara2017 年 5 月 12 日
Evaluation of Dosing Strategy for Pembrolizumab for Oncology Indications Publication Evaluation of Dosing Strategy for Pembrolizumab for Oncology Indications Certara2017 年 5 月 1 日